CINZITAB Cinnarizine 25mg Tablet 1's
Indications
Motion sickness; Management of vestibular symptoms; Cerebrovascular disorders; Peripheral circulatory disorders
Dosage
As 25 mg tab: 25 mg to be taken at least 30 minutes before travel, may be repeated 6 hourly if necessary. Child: As 25 mg tab: 6-12 years 12.5 mg to be taken at least 30 minutes before travel, may be repeated 6 hourly if necessary; ≥13 years Same as adult dose.
Administration
Administer with food.
Storage
Store between 15-30°C. Protect from light.
Contraindications
Hypersensitivity to cinnarizine or any component of the formulation. Refer to manufacturer labeling for further detail.
Precautions
Patient with Parkinson's disease. Avoid use in a patient with porphyria. Renal and hepatic impairment. Children. Pregnancy. Not recommended for use during breastfeeding.
Common side-effects
Sleepiness, Nausea, Weight gain, Indigestion
MedsGo Class
Antivertigo Drugs / Peripheral Vasodilators & Cerebral Activators
Features
- Cinnarizine